Senior insider sale
Chief Medical Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$653.1K
241.66K shares
FEINGOLD JAY plans to sell 241.66K shares of PYXIS ONCOLOGY, INC. valued at approximately $653.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/14/2023 | Restricted Stock Vesting Compensation | 50K | — |
| Total | 50K | ||
Completed
Units to sell
25K
Market value
$63.1K
Units to sell
25K
Market value
$64.6K
Units to sell
23.02K
Market value
$56.0K
Units to sell
27.36K
Market value
$71.4K
Units to sell
30K
Market value
$83.1K
Units to sell
234.00
Market value
$694.63
Units to sell
23.64K
Market value
$71.1K
Units to sell
37.40K
Market value
$116.7K
Planned — Approximate Date
Units to sell
50K
Market value
$126.5K
Units
241.66K
Value
$653.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/1/2023 | 25K | $63.1K | — | Completed |
7/31/2023 | 25K | $64.6K | — | Completed |
7/27/2023 | 23.02K | $56.0K | — | Completed |
7/21/2023 | 27.36K | $71.4K | — | Completed |
7/11/2023 | 30K | $83.1K | — | Completed |
6/16/2023 | 234.00 | $694.63 | — | Completed |
6/8/2023 | 23.64K | $71.1K | — | Completed |
6/7/2023 | 37.40K | $116.7K | — | Completed |
| Planned — Approximate Date | ||||
8/11/2023 | 50K | $126.5K | NASDAQ | Planned |
| Total | 241.66K | $653.1K | ||